157 related articles for article (PubMed ID: 31215439)
21. SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer.
Tong M; Luo S; Gu L; Wang X; Zhang Z; Liang C; Huang H; Lin Y; Huang J
Comput Biol Med; 2024 Mar; 171():108113. PubMed ID: 38368754
[TBL] [Abstract][Full Text] [Related]
22. DNA-based molecular classifiers for the profiling of gene expression signatures.
Zhang L; Liu Q; Guo Y; Tian L; Chen K; Bai D; Yu H; Han X; Luo W; Feng T; Deng S; Xie G
J Nanobiotechnology; 2024 Apr; 22(1):189. PubMed ID: 38632615
[TBL] [Abstract][Full Text] [Related]
23. Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis.
Chen C; Cai H; Shen J; Zhang X; Peng W; Li C; Lv H; Wen T
J Transl Med; 2024 Jan; 22(1):116. PubMed ID: 38287425
[TBL] [Abstract][Full Text] [Related]
24. A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection.
Atay S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958393
[TBL] [Abstract][Full Text] [Related]
25. Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways.
Liu L; Pang L; Wang Y; Hu M; Shao Z; Huo D; Zhang D; Xie H; Yang J; Liu Q; Chen X
Oncotarget; 2018 Apr; 9(30):21259-21267. PubMed ID: 29765536
[TBL] [Abstract][Full Text] [Related]
26. Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort study.
Armignacco R; Carlier N; Jouinot A; Birtolo MF; de Murat D; Tubach F; Hausfater P; Simon T; Gorochov G; Pourcher V; Beurton A; Goulet H; Manivet P; Bertherat J; Assié G;
Funct Integr Genomics; 2024 May; 24(3):107. PubMed ID: 38772950
[TBL] [Abstract][Full Text] [Related]
27. Pediatric Sepsis Endotypes Among Adults With Sepsis.
Wong HR; Sweeney TE; Hart KW; Khatri P; Lindsell CJ
Crit Care Med; 2017 Dec; 45(12):e1289-e1291. PubMed ID: 28991828
[TBL] [Abstract][Full Text] [Related]
28. A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.
Demirkol S; Gomceli I; Isbilen M; Dayanc BE; Tez M; Bostanci EB; Turhan N; Akoglu M; Ozyerli E; Durdu S; Konu O; Nissan A; Gonen M; Gure AO
J Cancer; 2017; 8(7):1113-1122. PubMed ID: 28607584
[No Abstract] [Full Text] [Related]
29. Immunological signature.
Visan I
Nat Immunol; 2023 Nov; 24(11):1781. PubMed ID: 37845491
[No Abstract] [Full Text] [Related]
30. Correction to: Featured lncRNA‑based signature for discriminating prognosis and progression of hepatocellular carcinoma.
Qiu H; Jiang B; Chen Y; Lin Z; Zheng W; Cao X
J Appl Genet; 2024 May; 65(2):415. PubMed ID: 38372890
[No Abstract] [Full Text] [Related]
31. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
Sun S; Li Y; Han S; Jia H; Li X; Li X
BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
[TBL] [Abstract][Full Text] [Related]
32. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.
Gao Q; Zhu H; Dong L; Shi W; Chen R; Song Z; Huang C; Li J; Dong X; Zhou Y; Liu Q; Ma L; Wang X; Zhou J; Liu Y; Boja E; Robles AI; Ma W; Wang P; Li Y; Ding L; Wen B; Zhang B; Rodriguez H; Gao D; Zhou H; Fan J
Cell; 2019 Oct; 179(2):561-577.e22. PubMed ID: 31585088
[TBL] [Abstract][Full Text] [Related]
33. Genetic Alterations and Transcriptional Expression of m
Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
Front Oncol; 2020; 10():900. PubMed ID: 32850303
[No Abstract] [Full Text] [Related]
34. Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices.
Cai JL; Zhu GQ; Du JX; Wang B; Wan JL; Xiao K; Dai Z
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):699-709. PubMed ID: 33131341
[No Abstract] [Full Text] [Related]
35. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
36. Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis.
Hu ZQ; Zhou SL; Li J; Zhou ZJ; Wang PC; Xin HY; Mao L; Luo CB; Yu SY; Huang XW; Cao Y; Fan J; Zhou J
Hepatology; 2020 Sep; 72(3):906-922. PubMed ID: 31838741
[TBL] [Abstract][Full Text] [Related]
37. A Pharmacogenomic Landscape in Human Liver Cancers.
Qiu Z; Li H; Zhang Z; Zhu Z; He S; Wang X; Wang P; Qin J; Zhuang L; Wang W; Xie F; Gu Y; Zou K; Li C; Li C; Wang C; Cen J; Chen X; Shu Y; Zhang Z; Sun L; Min L; Fu Y; Huang X; Lv H; Zhou H; Ji Y; Zhang Z; Meng Z; Shi X; Zhang H; Li Y; Hui L
Cancer Cell; 2019 Aug; 36(2):179-193.e11. PubMed ID: 31378681
[TBL] [Abstract][Full Text] [Related]
38. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma.
Wang B; Zhang Y
Open Med (Wars); 2020; 15(1):850-859. PubMed ID: 33336043
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Liao X; Yu T; Yang C; Huang K; Wang X; Han C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Deng J; Zeng X; Han B; Han Q; Liu Z; Zhou X; Liu J; Gong Y; Liu Z; Huang J; Lu L; Ye X; Peng T
J Cancer; 2019; 10(23):5689-5704. PubMed ID: 31737106
[No Abstract] [Full Text] [Related]
40. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
